{
    "clinical_study": {
        "@rank": "88889", 
        "arm_group": {
            "arm_group_label": "Ulthera treatment group", 
            "arm_group_type": "Experimental", 
            "description": "All subjects will receive an Ulthera System Treatment"
        }, 
        "brief_summary": {
            "textblock": "Up to 10 subjects will be enrolled. All subjects will receive an increased density\n      UltherapyTM treatment at dual depth.  Treatments will be provided to the lower 2/3 of the\n      face and neck.  Follow-up visits will occur at 90 and 180 days post-treatment.  Study images\n      will be obtained pre-treatment, 30-60 min post-treatment, and at each follow-up visit."
        }, 
        "brief_title": "Feasibility Study: Treatment of Post-surgery and Surgery Naive Patients Who Failed to Respond to a Previous Ulthera Treatment", 
        "completion_date": {
            "#text": "August 2012", 
            "@type": "Actual"
        }, 
        "condition": "Skin Laxity", 
        "condition_browse": {
            "mesh_term": "Cutis Laxa"
        }, 
        "detailed_description": {
            "textblock": "This is a prospective, single-site, non-randomized clinical trial efficacy of an additional\n      Ultherapy\u2122 treatment for subjects who were minimal or non-responders at Day 90 in a previous\n      Ulthera clinical trial. Global Aesthetic Improvement Scale scores and patient satisfaction\n      questionnaires will be obtained."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female, age 30 to 65 years.\n\n          -  Subject in good health.\n\n          -  BMI < 30.\n\n          -  Skin laxity in the submental area as demonstrated by a grade II or III on the Knize\n             scale for classification of cosmetic deformity of the cervicomental angle\n\n          -  Previous participation in ULT-107, and adequate compliance with all treatment and\n             follow-up visits.  Groups (surgery or surgery na\u00efve) will be designated based on\n             group assigned in ULT-107).\n\n          -  Have not had any concomitant surgical or skin tightening procedures since their\n             Ultherapy\u2122 treatment with ULT-107.\n\n        Exclusion Criteria:\n\n          -  Pregnant, lactating, or are planning to become pregnant, and/or not using a reliable\n             form of birth control.\n\n          -  Presence of an active systemic or local skin disease that may affect wound healing.\n\n          -  Severe solar elastosis.\n\n          -  Excessive subcutaneous fat on the cheeks.\n\n          -  Excessive skin laxity on the lower face and neck\n\n          -  Significant scarring in areas to be treated.\n\n          -  Open wounds or lesions in the area to be treated.\n\n          -  Severe or cystic acne on the area to be treated"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "4", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 7, 2011", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01708252", 
            "org_study_id": "ULT-127"
        }, 
        "intervention": {
            "arm_group_label": "Ulthera treatment group", 
            "description": "Focused ultrasound energy delivered below the surface of the skin", 
            "intervention_name": "Ulthera System Treatment", 
            "intervention_type": "Device", 
            "other_name": "Ultherapy\u2122"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Ulthera\u00ae System", 
            "Ultherapy\u2122 Treatment", 
            "Ulthera, Inc.", 
            "Ultrasound treatment for skin tightening"
        ], 
        "lastchanged_date": "June 28, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60611"
                }, 
                "name": "DeNova Research"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Feasibility Study: Evaluation of the Ulthera\u00ae System for Obtaining Lift and Tightening of the Neck in Post-Surgery and Surgery Naive Patients Who Failed to Respond to a Previous Ultherapy\u2122 Treatment", 
        "overall_official": {
            "affiliation": "DeNova Research", 
            "last_name": "Steven H Dayan, MD, FACS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Efficacy will be assessed using the 90-day images compared to baseline", 
                "measure": "Improvement in lower face and neck skin laxity", 
                "safety_issue": "No", 
                "time_frame": "90 days post-treatment"
            }, 
            {
                "description": "Efficacy will be assessed using the 90-day images compared to baseline.", 
                "measure": "Cervicomental angle", 
                "safety_issue": "No", 
                "time_frame": "90 days post-treatment"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01708252"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Principal Investigator and subject will complete a Global Aesthetic Improvement Scale at 90 days post-treatment.", 
                "measure": "Overall aesthetic improvement", 
                "safety_issue": "No", 
                "time_frame": "90 days post-treatment"
            }, 
            {
                "description": "Subjects will complete a Patient Satisfaction Questionnaire at 90 days post-treatment.", 
                "measure": "Patient satisfaction", 
                "safety_issue": "No", 
                "time_frame": "90 days post-treatment"
            }, 
            {
                "description": "Subject assessment of pain will be obtained using a 10-point validated Numeric Rating Scale following completion of each depth of treatment.", 
                "measure": "Pain Assessment", 
                "safety_issue": "Yes", 
                "time_frame": "Treatment visit"
            }, 
            {
                "description": "Subjects will complete a Patient Satisfaction Questionnaire at 180 days post-treatment.", 
                "measure": "Patient Satisfaction", 
                "safety_issue": "No", 
                "time_frame": "180 days post-treatment"
            }, 
            {
                "description": "Principal Investigator and subject will complete a Global Aesthetic Improvement Scale at 180 days post-treatment.", 
                "measure": "Overall aesthetic improvement", 
                "safety_issue": "No", 
                "time_frame": "180 days post-treatment"
            }
        ], 
        "source": "Ulthera, Inc", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ulthera, Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}